We are representing a number of plaintiffs who have Biomet hip lawsuits pending in this litigation. We are pleased to see these cases moving forward, and look ahead to even greater progress in the year to come.
New York, NY (PRWEB) November 22, 2013
The federal multidistrict litigation established in U.S. District Court, Northern District of Indiana, tasked with overseeing federal Biomet hip lawsuit (http://www.consumerinjurylawyers.com/biomet-magnum-hip-replacement) claims involving the M2a Magnum Hip Replacement System held its most recent Case Management Conference on November 18, 2013, Bernstein Liebhard LLP reports. According to a Memorandum issued by the Court on November 19th, topics addressed at that time included the status of discovery, proposed scheduling deadlines, and plaintiffs’ request for a special master. The Court also directed that the Biomet hip replacement litigation’s next Case Management Conference would be convened on January 6, 2014. (In re: Biomet M2a Magnum Hip Implant Products Liability Litigation – MDL No. 2391)
“We are representing a number of plaintiffs who have Biomet hip lawsuits pending in this litigation. We are pleased to see these cases moving forward, and look ahead to even greater progress in the year to come,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm continues to offer free and confidential Biomet hip lawsuit evaluations to individuals who may have been injured by the Biomet M2a Magnum Hip Replacement System.
Biomet Hip Replacement Lawsuits
Court records indicate that more than 700 Biome hip lawsuits have been filed in the Northern District of Indiana on behalf of individuals who suffered metallosis, pseudotumors, premature device failure, and other serious complications, allegedly due to the Biomet M2a Magnum Hip Replacement System. All of the cases involve similar allegations involving the metal-on-metal design of the M2a hip, which the lawsuits claim can shed dangerous amounts of toxic metal ions into recipients’ tissue and blood stream, leading to failure of the device within just a few years of implantation and need for revision surgery.
On January 17, 2013, the U.S Food & Drug Administration (FDA) issued a safety communication regarding all-metal hips, after finding that such devices were more prone to early failure than those made of other materials. Among other things, the agency has proposed regulations that would prevent metal-on-metal hips from being approved via the FDA 510(k) clearance program, which allowed the devices to come to market without premarket clinical testing. The proposed regulations would also require the manufacturers of metal-on-metal hips already on the market to conduct safety studies of those products in order to continue selling them. Finally, the FDA advised metal-on-metal hip recipients to undergo blood testing for high levels of metal ions if they experience any symptoms that could be a signal that their hip is failing.
Alleged victims of complications caused by the metal-on-metal design of the Biomet M2a Magnum hip replacement may be entitled to financial compensation for their medical bills, lost wages, pain and suffering, and other damages. For more information about Biomet hip lawsuits, as well as litigation involving other metal-on-metal hip implants, please visit Bernstein Liebhard LLP’s website. To arrange for a free case review, please call 800-511-5092.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 11 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP